WARNER-LAMBERT's QUINOLONE ENOXACIN NDA COVERS FIVE SEPARATE INDICATIONS, FIRM SAYS; R&D PROGRAM FEATURING CNS, CARDIOVASCULAR AND ANTICANCER PRODUCTS